Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Mok TSK, Kim SW, Wu YL, Nakagawa K, et al. Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses. J Clin Oncol 2017 Oct 2:JCO2017739250. doi: 10.1200/JCO.2017.73.9250.
PMID: 28968167


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016